The current status of tumor microenvironment and cancer stem cells in sorafenib resistance of hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a heterogeneous and aggressive liver cancer that presents limited treatment options. Despite being the standard therapy for advanced HCC, sorafenib frequently encounters resistance, emphasizing the need to uncover the underlying mechanisms and develop effective trea...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Siqi, Du, Yaqing, Guan, Xin-Yuan, Yan, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412930/
https://www.ncbi.nlm.nih.gov/pubmed/37576900
http://dx.doi.org/10.3389/fonc.2023.1204513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10412930/
https://www.ncbi.nlm.nih.gov/pubmed/37576900
http://dx.doi.org/10.3389/fonc.2023.1204513

Ejemplares similares